Shenzhen Baoyuan Medical Devices Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 40,000,000 on June 9, 2022. The transaction will involve participation from existing investor, Zhejiang Tailin BioEngineering Co.,Ltd. Post the closing, the registered capital of the company will increase from CNY 10,000,000 to CNY 50,000,000. Post-closing, the investor will retain its 100% stake in the company.